
Sunita Reddy
Examiner (ID: 846, Phone: (571)270-5151 , Office: P/3735 )
| Most Active Art Unit | 3791 |
| Art Unit(s) | RD00, 2491, 3791, 3735 |
| Total Applications | 826 |
| Issued Applications | 503 |
| Pending Applications | 83 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17761773
[patent_doc_number] => 20220235385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => ENGINEERED MICROORGANISMS AND METHODS FOR IMPROVED ALDEHYDE DEHYDROGENASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/605196
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605196 | ENGINEERED MICROORGANISMS AND METHODS FOR IMPROVED ALDEHYDE DEHYDROGENASE ACTIVITY | Apr 23, 2020 | Pending |
Array
(
[id] => 17685870
[patent_doc_number] => 20220193162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/600927
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600927 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Apr 15, 2020 | Pending |
Array
(
[id] => 17838045
[patent_doc_number] => 20220275350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => CIRCULARLY PERMUTATED HALOALKANE TRANSFERASE FUSION MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/604417
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604417 | Circularly permutated haloalkane transferase fusion molecules | Apr 15, 2020 | Issued |
Array
(
[id] => 17760043
[patent_doc_number] => 20220233655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => IMPROVED DELIVERY OF GENE THERAPY VECTORS TO RETINAL CELLS USING A GLYCOSIDE HYDROLASE ENZYME
[patent_app_type] => utility
[patent_app_number] => 17/611972
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611972 | IMPROVED DELIVERY OF GENE THERAPY VECTORS TO RETINAL CELLS USING A GLYCOSIDE HYDROLASE ENZYME | Apr 14, 2020 | Abandoned |
Array
(
[id] => 17705056
[patent_doc_number] => 20220205062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => USING SYNTHETIC LIXIVIANT BIOLOGY FOR THE RECOVERY OF PRECIOUS AND TOXIC METALS FROM ANTHROPOGENIC SOURCES
[patent_app_type] => utility
[patent_app_number] => 17/601802
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601802 | USING SYNTHETIC LIXIVIANT BIOLOGY FOR THE RECOVERY OF PRECIOUS AND TOXIC METALS FROM ANTHROPOGENIC SOURCES | Apr 7, 2020 | Pending |
Array
(
[id] => 17657052
[patent_doc_number] => 20220177517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => PROCESS FOR THE PURIFICATION OF RECOMBINANT POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/600276
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600276 | PROCESS FOR THE PURIFICATION OF RECOMBINANT POLYPEPTIDES | Apr 2, 2020 | Pending |
Array
(
[id] => 17627634
[patent_doc_number] => 20220162649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => NOVEL NUCLEIC ACID MODIFIERS
[patent_app_type] => utility
[patent_app_number] => 17/601052
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -135
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601052 | NOVEL NUCLEIC ACID MODIFIERS | Mar 31, 2020 | Abandoned |
Array
(
[id] => 17687689
[patent_doc_number] => 20220194981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => IMPROVEMENT OF AFFINITY CHROMATOGRAPHY OF IMMUNOGLOBULINS BY USING PRE-CAPTURE FLOCCULATION
[patent_app_type] => utility
[patent_app_number] => 17/601197
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601197
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601197 | IMPROVEMENT OF AFFINITY CHROMATOGRAPHY OF IMMUNOGLOBULINS BY USING PRE-CAPTURE FLOCCULATION | Mar 24, 2020 | Pending |
Array
(
[id] => 17642263
[patent_doc_number] => 20220170001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => Amylase Enzymes
[patent_app_type] => utility
[patent_app_number] => 17/442675
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442675 | Amylase Enzymes | Mar 23, 2020 | Pending |
Array
(
[id] => 18077812
[patent_doc_number] => 20220403424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Artificial Fusion of Dehydratase Enzymes to Improve Production of Fatty Acids
[patent_app_type] => utility
[patent_app_number] => 17/435709
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435709 | Artificial fusion of dehydratase enzymes to improve production of fatty acids | Mar 4, 2020 | Issued |
Array
(
[id] => 17776887
[patent_doc_number] => 20220243236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PRODUCTION OF CANNABINOIDS USING GENETICALLY ENGINEERED PHOTOSYNTHETIC MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/435695
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435695 | PRODUCTION OF CANNABINOIDS USING GENETICALLY ENGINEERED PHOTOSYNTHETIC MICROORGANISMS | Feb 27, 2020 | Abandoned |
Array
(
[id] => 17579168
[patent_doc_number] => 20220136023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => PRACTICAL ENZYMATIC SYNTHESIS OF 3',3'-CGAMP
[patent_app_type] => utility
[patent_app_number] => 17/435154
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435154
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435154 | PRACTICAL ENZYMATIC SYNTHESIS OF 3',3'-CGAMP | Feb 27, 2020 | Pending |
Array
(
[id] => 17563175
[patent_doc_number] => 20220127324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHOD FOR CONTINUOUS PRODUCTION OF RECOMBINANT GLP-1 PEPTIDE BY BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/429493
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429493 | Method for continuous production of recombinant GLP-1 peptide by bacteria | Feb 23, 2020 | Issued |
Array
(
[id] => 19871493
[patent_doc_number] => 12264342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/430013
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8878
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430013 | None | Feb 20, 2020 | Issued |
Array
(
[id] => 17370291
[patent_doc_number] => 20220025343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SELECTION
[patent_app_type] => utility
[patent_app_number] => 17/427974
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -109
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427974 | ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SELECTION | Feb 3, 2020 | Abandoned |
Array
(
[id] => 17548122
[patent_doc_number] => 20220119463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => MODIFIED FIBROIN
[patent_app_type] => utility
[patent_app_number] => 17/421243
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421243 | Modified fibroin | Jan 8, 2020 | Issued |
Array
(
[id] => 18597210
[patent_doc_number] => 20230272004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => RAMP TAG FOR INSULIN OVEREXPRESSION AND METHOD FOR MANUFACTURING INSULIN USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/418746
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418746
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418746 | RAMP TAG FOR INSULIN OVEREXPRESSION AND METHOD FOR MANUFACTURING INSULIN USING SAME | Dec 26, 2019 | Pending |
Array
(
[id] => 17471682
[patent_doc_number] => 20220079186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => LIQUID COMPOSITION COMPRISED OF A MICELLAR CASEIN CONCENTRATE
[patent_app_type] => utility
[patent_app_number] => 17/418319
[patent_app_country] => US
[patent_app_date] => 2019-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418319 | LIQUID COMPOSITION COMPRISED OF A MICELLAR CASEIN CONCENTRATE | Dec 23, 2019 | Abandoned |
Array
(
[id] => 19249053
[patent_doc_number] => 20240200040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => CHIMERIC DNA POLYMERASE AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/787955
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787955 | CHIMERIC DNA POLYMERASE AND APPLICATION THEREOF | Dec 22, 2019 | Pending |
Array
(
[id] => 17428399
[patent_doc_number] => 20220056107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Method for Filtering Fibrinogen
[patent_app_type] => utility
[patent_app_number] => 17/416143
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416143 | Method for Filtering Fibrinogen | Dec 19, 2019 | Pending |